663
Views
89
CrossRef citations to date
0
Altmetric
Research Article

Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2)

&
Pages 317-354 | Published online: 09 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Najmeh Ahangari, Mohammad Doosti, Majid Ghayour Mobarhan, Amirhossein Sahebkar, Gordon A. Ferns & Alireza Pasdar. (2020) Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy. Annals of Medicine 52:8, pages 462-470.
Read now
Yueling Yuan, Tiange Cai, Xi Xia, Ronghua Zhang, Peter Chiba & Yu Cai. (2016) Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Drug Delivery 23:9, pages 3350-3357.
Read now
Barbara Döring & Ernst Petzinger. (2014) Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism. Drug Metabolism Reviews 46:3, pages 261-282.
Read now
Rebecca Schnepf & Oliver Zolk. (2013) Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 9:3, pages 287-306.
Read now
Jing Li & Martin H Bluth. (2011) Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy. Pharmacogenomics and Personalized Medicine 4, pages 11-33.
Read now
Bruno Stieger & Peter J Meier. (2011) Pharmacogenetics of Drug Transporters in the Enterohepatic Circulation. Pharmacogenomics 12:5, pages 611-631.
Read now
Sarah Rofaiel, Esther N Muo & Shaker A Mousa. (2010) Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management. Pharmacogenomics and Personalized Medicine 3, pages 129-143.
Read now
Ekaitz Errasti-Murugarren & Marçal Pastor-Anglada. (2010) Drug Transporter Pharmacogenetics in Nucleoside-Based Therapies. Pharmacogenomics 11:6, pages 809-841.
Read now
Sook Wah Yee, Ligong Chen & Kathleen M Giacomini. (2010) Pharmacogenomics of Membrane Transporters: Past, Present and Future. Pharmacogenomics 11:4, pages 475-479.
Read now

Articles from other publishers (80)

Deyanira Escalante-Bautista, Doris Cerecedo, Elva Jiménez-Hernández, Carolina González-Torres, Javier Gaytán-Cervantes, Juan Carlos Núñez-Enríquez, Omar Alejandro Sepúlveda-Robles, Marlon De Ita, Silvia Jiménez-Morales, José Manuel Sánchez-López, Minerva Mata-Rocha, José Refugio Torres-Nava, Jorge Alfonso Martín-Trejo, Luz Victoria Flores-Villegas, María de Lourdes Gutiérrez-Rivera, Laura Elizabeth Merino-Pasaye, Karina Anastacia Solís-Labastida, María Raquel Miranda-Madrazo, Gabriela Alicia Hernández-Echáurregui, Darío Orozco-Ruíz, Janet Flores-Lujano, María Luisa Pérez-Saldívar, Juan Manuel Mejía-Aranguré & Haydeé Rosas-Vargas. (2024) Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia. Frontiers in Oncology 13.
Crossref
Sheena Sharma, Vijaya Saradhi Mettu & Bhagwat Prasad. (2023) Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats. Pharmaceutics 15:2, pages 542.
Crossref
Ayush Sharma, Prakash Kumar, Siddhartha Dutta, Rimple Jeet Kaur, Jaykaran Charan, Gaurav Chikara, Krishna Murti, Murali Kumarasamy, M. Ramesh, Krishna Pandey, V. Ravichandiran & Sameer Dhingra. (2022) Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes. Current Pharmacology Reports 8:6, pages 427-438.
Crossref
Marc‐Olivier Pilon, Grégoire Leclair, Essaïd Oussaïd, Isabelle St‐Jean, Martin Jutras, Marie‐Josée Gaulin, Ian Mongrain, David Busseuil, Jean Lucien Rouleau, Jean‐Claude Tardif, Marie‐Pierre Dubé & Simon de Denus. (2022) An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites . Clinical and Translational Science 15:8, pages 2024-2034.
Crossref
Mohini Singh & Bhaskar Mazumder. (2022) Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review. Pharmaceutical Nanotechnology 10:1, pages 42-55.
Crossref
Giovanna Revilla, Antonio Moral, José Ignacio Pérez, Victoria Fuste, Enrique Lerma, Enma Veronica Paez Espinosa, Josep Julve, Rosa Corcoy, Joan Carles Escolà-Gil & Eugènia Mato. 2022. Unraveling the Complexities of Metastasis. Unraveling the Complexities of Metastasis 265 275 .
Eliza R. McColl, Vessela Vassileva & Micheline Piquette-Miller. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 608 626 .
Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Licia Pensabene, Pierfrancesco Tassone & Pierosandro Tagliaferri. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 657 697 .
Iqra Younus, Sofia Kochkina, Cheri C. Choi, Wenjuan Sun & Robert C. Ford. 2022. Macromolecular Protein Complexes IV. Macromolecular Protein Complexes IV 35 82 .
Liam M. Koehn. 2022. The ADME Encyclopedia. The ADME Encyclopedia 1 10 .
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Vishakha Tambe, Bhagwat Sirsat, Kuldeep Rajpoot, Anuradha Gadeval & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations 355 385 .
Liam M. Koehn. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 10 .
Marcin Słomka, Marta Sobalska-Kwapis, Małgorzata Korycka-Machała, Jarosław Dziadek, Grzegorz Bartosz & Dominik Strapagiel. (2020) Comprehensive Analysis of ABCG2 Genetic Variation in the Polish Population and Its Inter-Population Comparison. Genes 11:10, pages 1144.
Crossref
Yun Kim, Seonghae Yoon, Yewon Choi, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu & Jae-Yong Chung. (2019) Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. Scientific Reports 9:1.
Crossref
Carolina I. Ghanem & Jose E. Manautou. (2019) Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics. Current Medicinal Chemistry 26:7, pages 1185-1223.
Crossref
Tony F. Grassi, Lucas T. Bidinotto, Gisele A.D. Lopes, Joyce R. Zapaterini, Maria A.M. Rodrigues & Luís F. Barbisan. (2019) Maternal western-style diet enhances the effects of chemically-induced mammary tumors in female rat offspring through transcriptome changes. Nutrition Research 61, pages 41-52.
Crossref
Y. W. Francis Lam. 2019. Pharmacogenomics. Pharmacogenomics 1 53 .
Simon Chewchuk, Tyler Boorman, Derek Edwardson & Amadeo M. Parissenti. (2018) Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells. Scientific Reports 8:1.
Crossref
P. Jungsuwadee & M. Vore. 2018. Comprehensive Toxicology. Comprehensive Toxicology 617 666 .
K.K. Wolf & M.F. Paine. 2018. Comprehensive Toxicology. Comprehensive Toxicology 74 98 .
Grace Angeline Malarnangai Kularatnam, Dilanthi Warawitage, Dinesha Maduri Vidanapathirana, Subashini Jayasena, Eresha Jasinge, Nalika de Silva, Kirinda Liyana Arachchige Manoj San Liyanarachchi, Pujitha Wickramasinghe, Manjit Singh Devgun, Veronique Barbu & Olivier Lascols. (2017) Dubin–Johnson syndrome and intrahepatic cholestasis of pregnancy in a Sri Lankan family: a case report. BMC Research Notes 10:1.
Crossref
Seyed Abbas Mirzaei, Neda Gholamian Dehkordi, Mahsa Ghamghami, Amir Hossein Amiri, Elaheh Dalir Abdolahinia & Fatemeh Elahian. (2017) ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Toxicology and Applied Pharmacology 337, pages 22-29.
Crossref
Alison E. Fohner, Deanna J. Brackman, Kathleen M. Giacomini, Russ B. Altman & Teri E. Klein. (2017) PharmGKB summary. Pharmacogenetics and Genomics 27:11, pages 420-427.
Crossref
Guillermo Gervasini, Silvia G. de Murillo, Mercedes Jiménez, María D. de la Maya & Jose M. Vagace. (2017) Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia. Gene 628, pages 72-77.
Crossref
S de Denus, J L Rouleau, D L Mann, G S Huggins, T P Cappola, S H Shah, J Keleti, Y F Zada, S Provost, A Bardhadi, M S Phillips, V Normand, I Mongrain & M-P Dubé. (2016) A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. The Pharmacogenomics Journal 17:2, pages 192-200.
Crossref
Frans J.C. Cuperus, Julien Gautherot, Emina Halilbasic, Thierry Claudel & Michael Trauner. 2017. Transporters as Drug Targets. Transporters as Drug Targets 119 166 .
Yogita A. Ghodke-Puranik & Jatinder K. Lamba. 2017. Innovative Approaches in Drug Discovery. Innovative Approaches in Drug Discovery 195 234 .
Kaitlin A. Doucette, Kelly N. Hassell & Debbie C. Crans. (2016) Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs. Journal of Inorganic Biochemistry 165, pages 56-70.
Crossref
B. A. Adeagbo, O. O. Bolaji, T. A. Olugbade, M. A. Durosinmi, R. A. Bolarinwa & C. Masimirembwa. (2016) Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia. Journal of Clinical Pharmacy and Therapeutics 41:5, pages 546-551.
Crossref
Shabbir Ahmed, Zhan Zhou, Jie Zhou & Shu-Qing Chen. (2016) Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics, Proteomics & Bioinformatics 14:5, pages 298-313.
Crossref
Zahra Salehi, Arshad Hosseini, Mohammad Najafi, Hussain Ahmad & Mohammad Reza Fayazi. (2016) Analysis of the Potential Associations of Two Common Polymorphisms in the ABCC1 Three Prime Untranslated Region With Breast Cancer Susceptibility. Thrita 5:2.
Crossref
Kristina K. Wolf, Brandon T. Gufford, Scott J. Brantley, Paul B. Watkins & Mary F. Paine. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 626 638 .
Zirui Wan, Guo Wang, Tailin Li, Biaobo Xu, Qi Pei, Yan Peng, Hong Sun, Lijuan Cheng, Ying Zeng, Guoping Yang & Yuan-Shan Zhu. (2015) Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote. Journal of Pharmacology and Experimental Therapeutics 354:3, pages 310-315.
Crossref
Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby, Connie T. Azumaya, Julie Zalikowski, Yusong Chen, Kenneth Kim & Helen J. Ambrose. (2015) Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States. European Journal of Clinical Pharmacology 71:3, pages 329-340.
Crossref
Yi-Jun Wang, Yun-Kai Zhang, Rishil Kathawala & Zhe-Sheng Chen. (2014) Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance. Cancers 6:4, pages 1925-1952.
Crossref
Yu-Chin Lin, Chung-Ping Yu, Shiuan-Pey Lin, Pei-Wen Hsu, Pei-Dawn Lee Chao, Yu-Chi Hou & Shin-Hun Juang. (2014) Potential modulation on BCRP and MRP 4 by onion: in vivo and ex-vivo studies. Journal of Functional Foods 8, pages 243-251.
Crossref
Frans J. C. Cuperus, Thierry Claudel, Julien Gautherot, Emina Halilbasic & Michael Trauner. (2014) The Role of Canalicular ABC Transporters in Cholestasis. Drug Metabolism and Disposition 42:4, pages 546-560.
Crossref
Mariusz Panczyk. (2014) Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World Journal of Gastroenterology 20:29, pages 9775.
Crossref
Shingen Misaka, Fabian Müller & Martin F Fromm. (2013) Clinical relevance of drug efflux pumps in the gut. Current Opinion in Pharmacology 13:6, pages 847-852.
Crossref
Marianne K. DeGorterRommel G. TironaUte I. SchwarzYun-Hee ChoiGeorge K. DresserNeville SuskinKathryn MyersGuangYong ZouOtito IwuchukwuWei-Qi WeiRussell A. WilkeRobert A. HegeleRichard B. Kim. (2013) Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care. Circulation: Cardiovascular Genetics 6:4, pages 400-408.
Crossref
Yan Zhou, Guo-Qiang Zhang, Yu-Hui Wei, Jian-Ping Zhang, Guo-Rong Zhang, Jiang-Xia Ren, Hao-Gang Duan, Zhi Rao & Xin-An Wu. (2013) The impact of drug transporters on adverse drug reaction. European Journal of Drug Metabolism and Pharmacokinetics 38:2, pages 77-85.
Crossref
Y.W. Francis Lam & Larisa H. Cavallari. 2013. Pharmacogenomics. Pharmacogenomics 1 44 .
Gerhard Burckhardt & Hermann Koepsell. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 2425 2455 .
Jaspreet Kaur, Beenish Rahat & Jyotdeep Kaur. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 707 741 .
Omer Faruk Hatipoglu, Onur Bender, Esra Gunduz & Mehmet Gunduz. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 237 248 .
John Dickenson, Fiona Freeman, Chris Lloyd Mills, Shiva Sivasubramaniam & Christian Thode. 2012. Molecular Pharmacology. Molecular Pharmacology 201 226 .
M Ansari, G Sauty, M Labuda, V Gagné, J Rousseau, A Moghrabi, C Laverdière, D Sinnett & M Krajinovic. (2011) Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal 12:5, pages 386-394.
Crossref
Kuan Gandelman, Gordon L. Fung, Michael Messig & Rachel Laskey. (2012) Systemic Exposure to Atorvastatin Between Asian and Caucasian Subjects. American Journal of Therapeutics 19:3, pages 164-173.
Crossref
Anthony Y. H. Lu & Qiang Ma. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development 95 107 .
Henriette E. Meyer zu Schwabedissen, Markus Grube & Heyo K. Kroemer. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy 101 148 .
M.K. DeGorterC.Q. Xia, J.J. Yang & R.B. Kim. (2012) Drug Transporters in Drug Efficacy and Toxicity. Annual Review of Pharmacology and Toxicology 52:1, pages 249-273.
Crossref
Stacy L. Gelhaus, Oren Gilad, Wei-Ting Hwang, Trevor M. Penning & Ian A. Blair. (2012) Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells. Toxicology Letters 209:1, pages 58-66.
Crossref
Torben S. Mikkelsen, Caroline F. Thorn, Jun J. Yang, Cornelia M. Ulrich, Deborah French, Gianluigi Zaza, Henry M. Dunnenberger, Sharon Marsh, Howard L. McLeod, Kathy Giacomini, Mara L. Becker, Roger Gaedigk, James Steven Leeder, Leo Kager, Mary V. Relling, William Evans, Teri E. Klein & Russ B. Altman. (2011) PharmGKB summary. Pharmacogenetics and Genomics 21:10, pages 679-686.
Crossref
V. Shane Pankratz, Zhifu Sun, Jeremiah Aakre, Yan Li, Cassandra Johnson, Yolanda I. Garces, Marie C. Aubry, Julian R. Molina, Dennis A. Wigle & Ping Yang. (2011) Systematic Evaluation of Genetic Variants in Three Biological Pathways on Patient Survival in Low-Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology 6:9, pages 1488-1495.
Crossref
Vandana Megaraj, Tianyong Zhao, Christian M. Paumi, Phillip M. Gerk, Richard B. Kim & Mary Vore. (2011) Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2). Pharmacogenetics and Genomics 21:8, pages 506-515.
Crossref
Qiang Ma & Anthony Y. H. Lu. (2011) Pharmacogenetics, Pharmacogenomics, and Individualized Medicine. Pharmacological Reviews 63:2, pages 437-459.
Crossref
Dylan M. Glubb & Federico Innocenti. (2010) Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters. WIREs Systems Biology and Medicine 3:3, pages 299-313.
Crossref
S Ehata, E Johansson, R Katayama, S Koike, A Watanabe, Y Hoshino, Y Katsuno, A Komuro, D Koinuma, M R Kano, M Yashiro, K Hirakawa, H Aburatani, N Fujita & K Miyazono. (2010) Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 30:14, pages 1693-1705.
Crossref
Arne Sl?tsve, Aina Ravna, Roy Lys?Georg Sager. (2011) ABC-transport?renes betydning for effekt og omsetning av legemidler. Tidsskrift for Den norske legeforening 131:11, pages 1084-1087.
Crossref
Mark Gumbleton, Ghaith Al-Jayyoussi, Adam Crandon-Lewis, Danielle Francombe, Katharina Kreitmeyr, Chris J. Morris & Mathew W. Smith. (2011) Spatial expression and functionality of drug transporters in the intact lung: Objectives for further research. Advanced Drug Delivery Reviews 63:1-2, pages 110-118.
Crossref
Jing Li, Martin H. Bluth & Andrea Ferreira-Gonzalez. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods 1359 1382 .
Min Zhao, YanMing Chen, DaCheng Qu & Hong Qu. (2011) TSdb: A database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates. Science China Life Sciences 54:1, pages 60-64.
Crossref
Henriette E. Meyer zu Schwabedissen & Heyo K. Kroemer. 2011. Drug Transporters. Drug Transporters 325 371 .
Maja Krajinovic. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia 315 330 .
John S. PattonJoseph D. BrainLee A. DaviesJennifer FiegelMark GumbletonKwang-Jin KimMasahiro SakagamiRita VanbeverCarsten Ehrhardt. (2010) The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23:S2, pages S-71-S-87.
Crossref
Curtis D. Klaassen & Lauren M. Aleksunes. (2010) Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation. Pharmacological Reviews 62:1, pages 1-96.
Crossref
Yuanyuan Zhang, Tianyong Zhao, Wei Li & Mary Vore. (2010) The 5′-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation. Molecular Pharmacology 77:2, pages 237-246.
Crossref
Kimberly K. Adkison, Soniya S. Vaidya, Daniel Y. Lee, Seok Hwee Koo, Linghui Li, Amar A. Mehta, Annette S. Gross, Joseph W. Polli, Joan E. Humphreys, Yu Lou & Edmund J.D. Lee. (2010) Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration. Journal of Pharmaceutical Sciences 99:2, pages 1046-1062.
Crossref
K.K. Wolf, M.F. Paine & P.B. Watkins. 2010. Comprehensive Toxicology. Comprehensive Toxicology 53 75 .
P. Jungsuwadee & M.E. Vore. 2010. Comprehensive Toxicology. Comprehensive Toxicology 557 601 .
Jeannie M. Padowski & Gary M. Pollack. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer 359 384 .
Hua He, William S Oetting, Marcia J Brott & Saonli Basu. (2009) Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene Interaction in a case-control study. BMC Medical Genetics 10:1.
Crossref
Marianne K. DeGorter & Richard B. Kim. (2009) Hepatic drug transporters, old and new: Pharmacogenomics, drug response, and clinical relevance. Hepatology 50:4, pages 1014-1016.
Crossref
Marc Ansari, Géraldine SautyMalgorzata LabudaVincent GagnéCaroline Laverdière, Albert Moghrabi, Daniel Sinnett & Maja Krajinovic. (2009) Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. Blood 114:7, pages 1383-1386.
Crossref
J E Keskitalo, O Zolk, M F Fromm, K J Kurkinen, P J Neuvonen & M Niemi. (2009) ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin. Clinical Pharmacology & Therapeutics 86:2, pages 197-203.
Crossref
Ivanise Marina Moretti Rebecchi, Alice Cristina Rodrigues, Simone Sorkin Arazi, Fabiana Dalla Vecchia Genvigir, Maria Alice Vieira Willrich, Mario Hiroyuki Hirata, Sarah Aparecida Soares, Marcelo Chiara Bertolami, André Arpad Faludi, Márcia Martins Silveira Bernik, Egidio Lima Dorea, Maria Lucia Zaidan Dagli, José Luis Avanzo & Rosario Dominguez Crespo Hirata. (2009) ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment. Biochemical Pharmacology 77:1, pages 66-75.
Crossref
Mariano Monzo, Alfons Navarro, Gerardo Ferrer & Rosa Artells. (2008) Pharmacogenomics: a tool for improving cancer chemotherapy. Clinical and Translational Oncology 10:10, pages 628-637.
Crossref
Hee-Jeong Ahn, Ji-Young Kim, Choong-Hwan Lee, Im-Sook Song & Kwang-Hyeon Liu. (2008) Screening of Chemosensitizer Candidates Using Natural Extracts. Journal of Life Science 18:9, pages 1244-1248.
Crossref
Aldo D Mottino & Viviana A Catania. (2008) Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents. World Journal of Gastroenterology 14:46, pages 7068.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.